2017
-
Experts discuss challenges in diagnosing and treating large-vessel vasculitis
Large-vessel vasculitis is a group of vasculitides that includes giant cell arteritis (GCA) and Takayasu’s arteritis (TAK), disorders that often present a diagnostic and therapeutic challenge to healthcare providers in rheumatology. While GCA and TAK share similarities, they differ in many aspects, and novel approaches…
-
Initiative works to increase African American participation in lupus clinical trials
The COllaborative INitiatives (COIN) department of the American College of Rheumatology (ACR) is currently working with ACR/ARHP members and external collaborators to develop educational materials for healthcare providers to increase participation of African Americans in lupus clinical trials. Once the materials are completed they will…
-
Don’t let Congress make decisions without you!
No one is more qualified than you to tell lawmakers how their policies affect your ability to provide quality care and your patients’ ability to access it. Think contacting your legislators doesn’t matter? Think again. Thanks to the diligence of ACR and ARHP members who…
-
What has Washington done to your practice?
In 2017, we saw the defeat of efforts to repeal the Affordable Care Act, the cancellation of the Medicare Part B Drug Reimbursement Project proposed by CMS, extended flexibilities in the MACRA program for physicians and small practices, and more. It is clearer than ever…
-
Foundation unveils 2017 Commemorative Gout Print
The Rheumatology Research Foundation is offering the latest in the Rodnan Commemorative Gout Print series for sale in the ACR Discovery Center in the Exhibit Hall. As both a vintage depiction of gout and a symbol of Foundation support, Rodnan Commemorative Gout Prints are coveted…
-
CORC biosimilars forum covers latest on on new therapies
Over the past few years, there have been breakthroughs in biologic therapies in the treatment of rheumatologic conditions. This has opened the door for new types of biological products such as biosimilars, a type of biological product that are highly similar in characteristics to their…
-
Thank you, supporters!
In addition to the support provided for the 2017 ACR/ARHP Annual Meeting, the ACR, the ARHP, and the Foundation wish to thank the following organizations for providing support for activities and programs throughout the year. AbbVie Corporate Roundtable, Leadership Level Fellows Education Fund State-of-the-Art Clinical…
-
Web, social media strategies improve outcomes for researchers, clinicians
This year’s TechMed sub-track includes two sessions that will focus on how clinicians and researchers can use digital and social media to directly engage with their colleagues, their patients, and the general public. During Sunday’s Using Social Media to Connect With & Recruit Patients…
-
2018 State-of-the-Art Clinical Symposium
Join the ACR for a weekend of high-impact education at the 2018 State-of-the-Art Clinical Symposium, held April 13 – 15, 2018, in Chicago. The program offers information on cutting-edge clinical best practices and evidence-based treatment, without interrupting your work week! Discover the most up-to-date information…
-
MACRA has arrived, and now it counts
Changes to reimbursement introduced by the Medicare Access and CHIP Reauthorization Act (MACRA) will affect your Medicare income for 2019. “Rheumatologists generally know that MACRA is up and running,” said Angus Worthing, MD, Clinical Assistant Professor of Rheumatology at Georgetown University Medical Center and Chair…